PWM
DFTX

Palumbo Wealth Management’s Definium Therapeutics DFTX Stock Holding History

Palumbo Wealth Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$718K Sell
37,966
-1,036
-3% -$17.6K 0.18% 91
2025
Q4 		$522K Buy
39,002
+6,073
+18% +$75.2K 0.13% 121
2025
Q3 		$388K Buy
32,929
+8,886
+37% +$82.9K 0.12% 113
2025
Q2 		$156K Buy
24,043
+1,415
+6% +$9.31K 0.05% 188
2025
Q1 		$132K Buy
+22,628
New +$162K 0.04% 176

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Palumbo Wealth Management's DFTX Position: Q1 2026 in Review

Palumbo Wealth Management reduced its Definium Therapeutics (DFTX) stake by 2.7% in Q1 2026, selling an estimated $17.6K and leaving 37,966 shares worth $718K. The position accounts for 0.18% of the portfolio, ranked #91.

Palumbo Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 5 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Palumbo Wealth Management held 37,966 shares of Definium Therapeutics worth $718K as of Q1 2026.
  • Palumbo Wealth Management sold 1,036 Definium Therapeutics shares in Q1 2026, an estimated $17.6K.
  • Definium Therapeutics made up 0.18% of Palumbo Wealth Management's portfolio in Q1 2026, its #91 holding.
  • Palumbo Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Palumbo Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.